Trial Profile
Double-Blind, Placebo Controlled, Randomized Clinical Trial Comparing Melatonin 3 mg, Amitriptyline 25 mg and Placebo for Migraine Prevention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2013
Price :
$35
*
At a glance
- Drugs Melatonin (Primary) ; Amitriptyline
- Indications Migraine
- Focus Therapeutic Use
- 30 Jun 2013 Results presented at the 2013 International Headache Congress.
- 23 Mar 2013 Results presented at the 65th Annual Meeting of the American Academy of Neurology.
- 28 Feb 2013 New trial record